Elevated levels of anti inflammatory IL-10 and pro inflammatory IL-17 in malignant pleural effusions

Table 1 Descriptive statistics

	N	Minimum	Maximum	Mean	Std. Deviation
IL- 17 B	24	18.258	31.605	23.63281	3.553243
IL-10 B	24	.00	112.43	13.8533	28.72131
IL-17 P	24	21.009	33.020	24.97380	3.595384
IL-10 P	24	1.75	229.83	60.1112	59.13965
WBC	24	2.3	30.6	10.296	5.5273
RBC	24	3.16	5.17	3.9788	.53680
HCT	24	28.4	46.5	36.192	4.7277
PLT	24	87	658	283.71	117.411
HB	24	9	16	12.02	1.675
GR%	24	43.5	93.8	71.912	10.7272
MONO%	24	.8	30.6	9.846	6.6490
LYMPH%	24	1.4	32.1	17.308	7.5535
AGE	24	37	74	60.42	10.270
GENDER	24	1	2	1.63	.495
AGEgroup	24	1	3	2.50	.659
primary1	24	1	2	1.63	.495
TYPE_3_UN	24	1	3	2.04	.624
chemo1yes	24	0	1	.58	.504
Valid N (listwise)	24

IL-17B Interleukin 17 levels in Blood, IL-10B Interleukin 10 levels in Blood, IL-17P Interleukin 17 levels in Pleural Fluid, IL-10P Interleukin 10 levels in Pleural Fluid, WBC White Blood Cells Count, RBC Red Blood Cells Count, HCT Heamatocrit, PLT Platelets, HB Heamoglobulin, GR% Granulocytes percentage, MONO% Monocytes percentage, LYMPH% Lymphocytes percentage, AGE Age, GENDER Gender, AGEgroup 1 = age 1 to 39, 2 = 40 to 59, 3 = 60 and above, Primary1 1 = Lung cancer, 2 = other, TYPE_3_UN 1 = NSCLC,SCLC,AdenoCa Lung/2 = other malignancy/3 = Unknown origin of malignancy, chemo1yes chemotherapy done = 1.

ISSN: 1749-8090